A Randomized, Open-label, Multicenter Trial of the Chemoradiation Versus Standard Esophagectomy for Locally Advanced Resectable Esophageal Squamous Cell Cancer in Chinese Patients (CELAEC)

NCT02972372 NA RECRUITING

The aim of this study is to compare outcomes in Chinese patients with locally advanced resectable esophageal squamous cell cancer who have received either surgery or definitive chemoradiation (CRT) by the randomized, open-label, multicenter trial.

Details

Lead sponsor	The First Affiliated Hospital of Henan University of Science and Technology
Phase	NA
Status	RECRUITING
Enrolment	196
Start date	2016-11
Completion	2027-12

Conditions

• Esophagus Cancer

Interventions

• CRT
• surgery

Primary outcomes

• 2-year disease-free survival rate — 2 year
  The percent of 2 year disease-free survival after random allocation, percent

Countries

China